Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy.
Chierigo F, Flammia RS, Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Montorsi F, Chun FKH, Shariat SF, Antonelli A, Guano G, Mantica G, Borghesi M, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: chun fkh. Arab J Urol. 2022 Nov 21;21(3):135-141. doi: 10.1080/2090598X.2022.2148867. eCollection 2023. Arab J Urol. 2022. PMID: 37521449 Free PMC article.
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy.
Chierigo F, Flammia RS, Sorce G, Hoeh B, Hohenhorst L, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Montorsi F, Chun FKH, Shariat SF, Guano G, Mantica G, Borghesi M, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: chun fkh. Prostate. 2023 May;83(7):695-700. doi: 10.1002/pros.24505. Epub 2023 Mar 15. Prostate. 2023. PMID: 36919872
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis.
Morra S, Incesu RB, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, Goyal JA, Tian Z, Saad F, Califano G, la Rocca R, Capece M, Shariat SF, Ahyai S, Carmignani L, de Cobelli O, Musi G, Tilki D, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Morra S, et al. Among authors: chun fkh. Cancers (Basel). 2023 Sep 10;15(18):4498. doi: 10.3390/cancers15184498. Cancers (Basel). 2023. PMID: 37760467 Free PMC article.
Incidence, Characteristics and Survival Rates of Bladder Cancer after Rectosigmoid Cancer Radiation.
Angelis M, Siech C, Di Bello F, Peñaranda NR, Goyal JA, Tian Z, Longo N, Chun FKH, Puliatti S, Saad F, Shariat SF, Longoni M, Gandaglia G, Moschini M, Montorsi F, Briganti A, Karakiewicz PI. Angelis M, et al. Among authors: chun fkh. Cancers (Basel). 2024 Jun 29;16(13):2404. doi: 10.3390/cancers16132404. Cancers (Basel). 2024. PMID: 39001466 Free PMC article.
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study.
Preisser F, Abrams-Pompe RS, Stelwagen PJ, Böhmer D, Zattoni F, Magli A, Rivas JG, Dilme RV, Sepulcri M, Eguibar A, Heidegger I, Arnold C, Fankhauser CD, Chun FK, van der Poel H, Gandaglia G, Wiegel T, van den Bergh RCN, Tilki D; EAU-YAU Prostate Cancer Working Group. Preisser F, et al. Eur Urol. 2024 Feb;85(2):164-170. doi: 10.1016/j.eururo.2023.05.038. Epub 2023 Jun 22. Eur Urol. 2024. PMID: 37355358
Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer.
Mader N, Nguyen Ngoc C, Kirkgöze B, Baumgarten J, Groener D, Klimek K, Happel C, Tselis N, Chun FKH, Grünwald F, Sabet A. Mader N, et al. Among authors: chun fkh. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1811-1821. doi: 10.1007/s00259-023-06119-1. Epub 2023 Jan 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 36702927 Free PMC article.
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial.
Krug D, Imhoff D, Haidenberger A, Heßler N, Schäfer J, Huttenlocher S, Chatzikonstantinou G, Fürweger C, Ramm U, König IR, Chun F, Staehler M, Rödel C, Muacevic A, Vonthein R, Dunst J, Blanck O. Krug D, et al. Strahlenther Onkol. 2023 Jun;199(6):565-573. doi: 10.1007/s00066-023-02044-2. Epub 2023 Feb 9. Strahlenther Onkol. 2023. PMID: 36757424 Free PMC article.
517 results